-
Mashup Score: 1Evidence-Based Use of Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration | Ophthalmic Surgery, Lasers and Imaging Retina - 1 month(s) ago
Indicated for colorectal cancer for decades, bevacizumab has been widely used off label to treat retinal diseases, and the benefits of its use, specifically in neovascular age-related macular degeneration, have been demonstrated in multiple clinical …
Source: journals.healio.comCategories: General Medicine News, OphthalmologyTweet
This narrative review summarizes the evidence and discusses the role of off-label #bevacizumab in the treatment and management of #retinaldiseases. #ophthalmology https://t.co/STxPkgqFEt